IMMUNOLOGY QUALITY ASSESSMENT PROGRAM

免疫学质量评估项目（IQA）的目的是继续并提供一种资源，以(1)评估美国和非美国医学工作者的能力。实验室准确可靠地进行研究指定的免疫学测试（重点是CD4和CD8 T细胞淋巴细胞计数和百分比）和可行的PBMC冷冻，(2)在发现缺陷时提供建议和培训，(3)评估基于免疫学的新技术（重点是用于诊断和疾病监测的新颖、简单的测试），以便在多地点NIAID试验中实施，(4)维护计算机化的数据管理系统和文档库，包括实验室性能数据和指导文件。IQA将继续支持属于当前和未来niaid资助的临床试验网络的实验室

The purpose of the Immunology Quality Assessment Program (IQA) is to continue and provide a resource to (1) evaluate the abilities of U.S. and non-U.S. laboratories to accurately and reliably perform study-specified immunological tests (with focus on CD4 and CD8 T cell lymphocyte counts and percentages) and viable PBMC freezing, (2) advise and train when deficiencies are identified, (3) evaluate immunology-based novel technologies (with focus on novel, simple tests for diagnosis and disease monitoring) for implementation in multi-site NIAID trials, and (4) maintain a computerized data management system and document library that include lab performance data and guidance documents. IQA will continue to support laboratories that are part of current and future NIAID-sponsored clinical trial networks